Page 21 - SARS-COV-2-laboratory-viral-outbreak-perspective-investigation-by-ICR-NIH-MY

Limitation

We had a few limitations but this was in the early phase. Firstly, there was a lack of local
suppliers and unavailability of local production for laboratory supplies has caused a
significant delay in securing adequate supply for the laboratories. Furthermore, the major
laboratory supply producing countries are also affected by COVID-19 outbreak which makes
the situation worse. For example, Korea, Germany and also Italy.

Secondly, during the early phase of pandemic, there was a sudden increase in workload
beyond the maximum laboratory capacity and the limited capacity of outsourcing
laboratories, has caused delay in laboratory Turnaround Time (TAT) for testing. This
occurred after Epid week 12 where we had a cluster in a religious group at Sri Petaling.
However, we managed to overcome the limitation by upscaling the country laboratory
capacity.

Few words before I end. We test, we manage and we must win. So that’s all. Pass back to
Datuk Dr Chris.

Slide presentation: https://cutt.ly/mpPwPBT

Video: https://youtu.be/2enmIG6cSl0